Evaluation of an ELISA for canine leishmaniasis immunodiagnostic using recombinant proteins

Parasite Immunology

Volumn 34, Issue 1, 2012, Pages 1-7

  de Souza, C M ^a   Silva, E D ^a   Ano Bom, A P D ^a   Bastos, R C ^a   Nascimento, H J ^a   da Silva Junior, J G ^a  

^a Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Enzyme immunoassay; Leishmania antigens; Protein purification; Recombinant proteins

Indexed keywords

RECOMBINANT PROTEIN; RLCI1A PROTEIN; RLCI2B PROTEIN; UNCLASSIFIED DRUG; UREA;

ANIMAL TISSUE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BABESIA; BABESIOSIS; CELL DISRUPTION; CELL INCLUSION; CROSS REACTION; DENATURING GRADIENT GEL ELECTROPHORESIS; DOG; EHRLICHIA CANIS; EHRLICHIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOASSAY; ISOELECTRIC FOCUSING; LEISHMANIA CHAGASI; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TRYPANOSOMA; TRYPANOSOMA CANINUM; TRYPANOSOMIASIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, ION EXCHANGE; CROSS REACTIONS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEISHMANIA INFANTUM; LEISHMANIASIS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 83655211381     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01334.x     Document Type: Article

References (35)

1. Piscopo TV & Mallia AC. Leishmaniasis. Postgrad Med J 2006; 82: 649-657.
2. Palatnik-de-Sousa CB, Santos WR, Franca-Silva JC, et al. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am J Trop Med Hyg 2001; 65: 510-517.
3. Singh S. New developments in diagnosis of leishmaniasis. Indian J Med Res 2006; 123: 311-330.
4. Zijlstra EE & El-Hassan AM. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95: S27-S58.
5. Wilson ME & Streit JA. Visceral leishmaniasis. Gastroenterol Clin North Am 1996; 25: 535-551.
6. Balanco JMF. Mimetismo apoptótico em Leishmania sp: papel na interação parasito/hospedeiro. [Dissertation]. São Paulo, Universidade de São Paulo (USP), 2005.
7. Bisugo MC. Leishmaniose visceral americana no estado de São Paulo, Brasil. Avaliação do diagnóstico da leishmaniose visceral canina com a utilização de teste rápido com antígeno recombinante K39. [Dissertation]. São Paulo, Instituto Adolfo Lutz, 2007.
8. Lira RA. Diagnóstico da leismaniose visceral canina: Avaliação do desempenho dos kits EIE-leishmaniose-visceral-canina-Bio-Manguinhos e IFI-leishmaniose-visceral-canina-Bio-Manguinhos. [Dissertation]. Recife, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, 2005.
9. Gomes YM, Paiva Cavalcanti M, Lira RA, Abath FGC & Alves LC. Diagnosis of canine visceral leishmaniasis: biotechnological advances. Vet J 2008; 175: 45-52.
10. Alberts B, Bray D, Lewis J, Raff M, Roberts K & Watson JD. Molecular Biology of the Cell, 4th edn. Porto Alegre, Artmed, 2006.
11. Afrin F, Rajesh R, Anam K, Gopinath M, Pal S & Ali N. Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice. Infect Immun 2002; 70: 6697-6706.
12. Soussi N, Milon G, Colle JH, Mougneau E, Glaichenhaus N & Goossens PL. Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen in Leishmania major. Infect Immun 2000; 68: 1498-1506.
13. Chakrabarty R, Mukherjee S, Lu HG, McGwire BS, Chang KP & Basu MK. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG). J Parasitol 1996; 82: 632-635.
14. Ahmed S, Colmenares M, Soong L, et al. Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun 2003; 71: 401-410.
15. White AC Jr & McMahon-Pratt D. Purification and characterization of an 80- kilodalton membrane protein from Leishmania donovani. Infect Immun 1988; 56: 2385-2391.
16. Bhatia A, Daifalla NS, Jen S, et al. Cloning characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol Biochem Parasite (Amsterdam) 1999; 102: 249-261.
17. Price VL & Kieny MP. Vaccines for parasitic diseases. Curr Drug Targets 2001; 1: 315-324.
18. Martins DRA, Jeronimo SMB, Donelson JE & Wilson ME. Leishmania chagasi T-cell antigens identified through a double library screen. Infect Immun, 2006; 74: 6940-6948.
19. Campos RM. Caracterização molecular de antígenos de Leishmania (Leishmania) chagasi potencialmente úteis no controle da leishmaniose visceral. [Dissertation]. Recife, Centro de Pesquisas Aggeu Magalhães, FIOCRUZ, 2007.
20. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007; 5: 873-882.
21. Kumar R, Pai K, Pathak K, et al. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis. Clin Diagn Lab Immunol 2001; 8: 1220-1224.
22. Buchner J. Supervising the fold: functional principles of molecular chaperones. FASEB J 1996; 10: 10-19.
23. Scalone A, De Luna R, Oliva G, et al. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Vet Parasitol 2002; 104: 275.
24. Rudolph R & Lilie H. In vitro folding of inclusion body proteins. Reviews. FASEB J 1996; 10: 49-56.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 1970; 227: 680-685.
26. Schägger H & von Jagger G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100kDa. Anal Biochem 1987; 166: 368-379.
27. Towbin H, Staehelin T & Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350-4354.
28. Peterson GL. Determination of total protein. Methods Enzymol 1983; 91: 95-105.
29. Nakane PK & Kawaoi A. Peroxidase - labeled antibody a new method of conjugation. J Histochem Cytochem 1974; 22: 1084-1091.
30. Ferreira AW & Ávila SLM. Diagnóstico Laboratorial das Principais Doenças Infecciosas e Auro-Imunes. Rio de Janeiro, Guanabara Koogan, 2001.
31. Thrusfield M., Ortega C, de Blas I, et al. WIN EPISCOPE 2.0: improved epidemiological software for veterinary medicine. Vet Rec 2001; 148: 567-572.
32. Braz RF, Nascimento ET, Martins DR, et al. The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of american visceral leishmaniasis and in differentiating active from subclinical infection. Am J Trop Med Hyg 2002; 67: 344-348.
33. Rosati S, Ortoffi M, Profiti M, et al. Prokariotic expression and antigenic characterization of three recombinant Leishmania antigens for serological diagnosis of canine leishmaniasis. Clin Diagn Lab Immunol 2003; 10: 1153-1156.
34. Boarino A, Scalone A, Gradoni L, et al. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 2005; 12: 647-653.
35. Luciano RM, Lucheis SB, Troncarelli MZ, Luciano DN & Langoni H. Cross reaction evaluation of Leishmania spp and Trypanosoma cruzi antigens in dogs' serologic response by indirect immunofluorescence test (IIF). Braz J Vet Res Anim Sci São Paulo, 2009; 46:3: 181-187.